-transparent.png){kind=logo}
The aim of this paper was to present the use of Cefamandole as one of the elements in perioperative prophylactics in total hip replacement. One hundred patients operated between 1993 and 1995 were followed-up for mean 13.5 months. There were 33 males and 67 females, mean age was 61.4 years. Cefamandole was administered according to fixed protocol for three days (first dose along with premedication). Mono-antibiotic therapy was sufficient in most cases. No septic complication occurred, no side-effects of Cefamandole were recorded. The patients are still being followed-up. Results achieved resemble these from the literature so conclusion can be made, that Cefamandole is safe and efficient drug for peri-operative prophylactics in total hip replacement.
M Jackowiak, and
T Buczkowski
October 1987,
The Journal of bone and joint surgery. American volume,
M Jackowiak, and
T Buczkowski
July 1988,
The Journal of bone and joint surgery. American volume,
M Jackowiak, and
T Buczkowski
June 1993,
Ugeskrift for laeger,
M Jackowiak, and
T Buczkowski
March 1988,
Clinical orthopaedics and related research,
M Jackowiak, and
T Buczkowski
February 1988,
Ugeskrift for laeger,
M Jackowiak, and
T Buczkowski
November 1984,
Ugeskrift for laeger,
M Jackowiak, and
T Buczkowski
November 1997,
Ugeskrift for laeger,
M Jackowiak, and
T Buczkowski
January 1988,
Archives of orthopaedic and traumatic surgery. Archiv fur orthopadische und Unfall-Chirurgie,
M Jackowiak, and
T Buczkowski
May 1996,
Ugeskrift for laeger,
M Jackowiak, and
T Buczkowski
June 1991,
Ugeskrift for laeger,
